Kevin J. Cullen

10.7k total citations · 2 hit papers
163 papers, 6.7k citations indexed

About

Kevin J. Cullen is a scholar working on Molecular Biology, Oncology and Otorhinolaryngology. According to data from OpenAlex, Kevin J. Cullen has authored 163 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 44 papers in Oncology and 40 papers in Otorhinolaryngology. Recurrent topics in Kevin J. Cullen's work include Head and Neck Cancer Studies (40 papers), Growth Hormone and Insulin-like Growth Factors (20 papers) and Cervical Cancer and HPV Research (16 papers). Kevin J. Cullen is often cited by papers focused on Head and Neck Cancer Studies (40 papers), Growth Hormone and Insulin-like Growth Factors (20 papers) and Cervical Cancer and HPV Research (16 papers). Kevin J. Cullen collaborates with scholars based in United States, Australia and Nigeria. Kevin J. Cullen's co-authors include Lisa M. Schumaker, Marc E. Lippman, Audrey Rasmussen, Zejia Yang, Olga Goloubeva, Neal Rosen, Robert I. Haddad, Marshall R. Posner, Nicholas J. Sarlis and Douglas Yee and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Kevin J. Cullen

154 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial

2011 353 citations Marshall R. Posner, Jochen H. Lorch et al. Annals of Oncology profile →
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

2011 310 citations Jochen H. Lorch, Olga Goloubeva et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin J. Cullen United States	46	2.2k	2.1k	1.7k	1.5k	1.0k	163	6.7k
Andrew G. Sikora United States	46	1.6k 0.7×	2.7k 1.3×	1.6k 0.9×	1.6k 1.1×	567 0.6×	178	6.9k
Terry A. Day United States	46	1.7k 0.8×	2.4k 1.1×	2.9k 1.7×	2.5k 1.7×	325 0.3×	188	7.8k
Marsha E. Reichman United States	36	1.1k 0.5×	2.1k 1.0×	314 0.2×	878 0.6×	490 0.5×	65	7.7k
Richard V. Smith United States	38	1.4k 0.6×	1.5k 0.7×	1.7k 1.0×	1.6k 1.1×	125 0.1×	196	5.3k
Bhumsuk Keam South Korea	50	2.1k 1.0×	6.1k 2.9×	573 0.3×	1.4k 0.9×	743 0.7×	373	9.9k
T. Tong United States	9	1.8k 0.8×	3.2k 1.5×	291 0.2×	1.5k 1.0×	289 0.3×	9	7.9k
Martin Krapcho United States	10	1.3k 0.6×	3.6k 1.7×	272 0.2×	1.3k 0.9×	302 0.3×	14	8.2k
Milton P. Eisner United States	5	1.3k 0.6×	3.6k 1.7×	242 0.1×	1.3k 0.9×	308 0.3×	10	8.1k
Matt Hayat United States	5	1.3k 0.6×	3.3k 1.6×	242 0.1×	1.2k 0.8×	296 0.3×	6	7.9k
B. Miller United States	5	1.3k 0.6×	3.6k 1.7×	239 0.1×	1.2k 0.8×	314 0.3×	6	8.2k

Countries citing papers authored by Kevin J. Cullen

Since Specialization

Citations

This map shows the geographic impact of Kevin J. Cullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin J. Cullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin J. Cullen more than expected).

Fields of papers citing papers by Kevin J. Cullen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin J. Cullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin J. Cullen. The network helps show where Kevin J. Cullen may publish in the future.

Co-authorship network of co-authors of Kevin J. Cullen

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin J. Cullen. A scholar is included among the top collaborators of Kevin J. Cullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin J. Cullen. Kevin J. Cullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liao, Jipei, et al.. (2024). Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co‐targeting EGFR and PI3K in cisplatin‐resistant HNSCC. Head & Neck. 46(5). 1126–1135. 5 indexed citations

Brown, Jessica, Rodney J. Taylor, Jeffrey S. Wolf, et al.. (2023). Regionalization of Head and Neck Oncology Tumor Boards: Perspectives of Collaborating Physicians. OTO Open. 7(1). e18–e18. 2 indexed citations

Yang, Zejia, Jipei Liao, Lisa M. Schumaker, et al.. (2022). Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma. Oral Oncology. 131. 105939–105939. 8 indexed citations

Amr, Sania, et al.. (2021). Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma. Head & Neck. 43(12). 3935–3945. 4 indexed citations

McCusker, Michael G., Ranee Mehra, Sania Amr, et al.. (2021). Comparison of efficacy and toxicity of chemoradiation regimens for head and neck squamous cell carcinoma primary treatment. Head & Neck. 44(3). 749–759. 3 indexed citations

Ezelle, Heather J., et al.. (2020). A Translational Approach to Cancer Research, Education and Training. Journal of Cancer Education. 36(3). 621–629. 2 indexed citations

Comiskey, Catherine, et al.. (2018). The BREATHE Project, a mobile application, video-monitoring system in family homes as an aid to the caring role: Needs, acceptability and concerns of informal carers. Digital Health. 4. 1343135030–1343135030. 6 indexed citations

Li, Zhipeng, Jipei Liao, Zejia Yang, et al.. (2018). Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer. British Journal of Cancer. 120(3). 306–316. 13 indexed citations

Wong, Stuart J., Theodore Karrison, D. Neil Hayes, et al.. (2015). Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Annals of Oncology. 27(2). 318–323. 73 indexed citations

10.

Zandberg, Dan P., Sandy Liu, Olga Goloubeva, Lisa M. Schumaker, & Kevin J. Cullen. (2014). Emergence of HPV16-Positive Oropharyngeal Cancer in Black Patients Over Time: University of Maryland 1992–2007. Cancer Prevention Research. 8(1). 12–19. 25 indexed citations

11.

DʼSouza, Gypsyamber, Kevin J. Cullen, Janice Bowie, Roland J. Thorpe, & Carole Fakhry. (2014). Differences in Oral Sexual Behaviors by Gender, Age, and Race Explain Observed Differences in Prevalence of Oral Human Papillomavirus Infection. PLoS ONE. 9(1). e86023–e86023. 163 indexed citations

12.

House, Michael G., et al.. (2012). Role of Neurofilament Light Polypeptide in Head and Neck Cancer Chemoresistance. Molecular Cancer Research. 10(3). 305–315. 24 indexed citations

13.

Posner, Marshall R., Lisa M. Schumaker, Ming Tan, et al.. (2009). Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients. Cancer Prevention Research. 2(9). 776–781. 221 indexed citations

14.

Scheper, Mark A., Ashraf Badros, Risa Chaisuparat, Kevin J. Cullen, & Timothy F. Meiller. (2008). Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate‐associated osteonecrosis. British Journal of Haematology. 144(5). 667–676. 122 indexed citations

15.

Cullen, Kevin J.. (2003). Work and family in the eWork era. 6 indexed citations

16.

Cullen, Kevin J. & Simon Robinson. (1997). Telecommunications for Older People and Disabled People in Europe : Preparing for the Information Society. 1 indexed citations

17.

Lake, Fiona, Kevin J. Cullen, Nicholas de Klerk, M. G. McCall, & D L Rosman. (1989). ATRIAL FIBRILLATION AND MORTALITY IN AN ELDERLY POPULATION. Australian and New Zealand Journal of Medicine. 19(4). 321–326. 183 indexed citations

18.

Masarei, J.R.L., D. H. Curnow, Kevin J. Cullen, et al.. (1971). Lipoprotein Electrophoretic Patterns, Serum Lipids, and Coronary Heart Disease. BMJ. 1(5740). 78–82. 12 indexed citations

19.

Cullen, Kevin J., et al.. (1970). Additional Factors in Chronic Bronchitis. BMJ. 1(5693). 394–395. 4 indexed citations

20.

Cullen, Kevin J., N. S. Stenhouse, Timothy A. Welborn, M. G. McCall, & D. H. Curnow. (1968). CHRONIC RESPIRATORY DISEASE IN A RURAL COMMUNITY. The Lancet. 292(7569). 657–660. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact